Volitionrx (VNRX) Interest Expenses (2011 - 2025)
Volitionrx (VNRX) posted Interest Expenses of -$83107.0 for Q4 2025, down 113.0% on a QoQ basis from $639271.0 in Q3 2025, and down 189.85% year-over-year from $92491.0 in Q4 2024.
Volitionrx (VNRX) Interest Expenses (2011 - 2025) Analysis & Trends
Volitionrx's Interest Expenses history runs 15 years deep, the most recent figure standing at -$83107.0 for Q4 2025.
- Quarterly Interest Expenses fell 189.85% year-over-year to -$83107.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $156839.0 (down 47.23% YoY) and the FY2025 annual result came in at $49.8 million, up 18.85% from the prior year.
- Interest Expenses was -$83107.0 for Q4 2025 at Volitionrx, down from $639271.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $647154.0 in Q1 2023 and bottomed at -$83107.0 in Q4 2025.
- A 5-year average of $362846.2 and a median of $451942.5 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses surged 2581.88% — and 2025, when it sank 189.85%.
- Volitionrx's Interest Expenses stood at $35167.0 in 2021, then jumped by 62.79% to $57250.0 in 2022, then gained by 1.31% to $57999.0 in 2023, then jumped by 59.47% to $92491.0 in 2024, then sank by 189.85% to -$83107.0 in 2025.
- Business Quant data shows VNRX's Interest Expenses at -$83107.0 in Q4 2025, $639271.0 in Q3 2025, and $435237.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | -83,107.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -83,107.00 |
| Dec 31, 2025 | -83,107.00 |
| Sep 30, 2025 | 639,271.00 |
| Sep 30, 2025 | 639,271.00 |
| Jun 30, 2025 | 435,237.00 |
| Jun 30, 2025 | 435,237.00 |
| Mar 31, 2025 | 414,674.00 |
| Mar 31, 2025 | 414,674.00 |
| Dec 31, 2024 | 92,491.00 |
| Dec 31, 2024 | 92,491.00 |
| Sep 30, 2024 | 89,456.00 |
| Sep 30, 2024 | 89,456.00 |
| Jun 30, 2024 | 453,848.00 |
| Jun 30, 2024 | 453,848.00 |
| Mar 31, 2024 | 472,433.00 |
| Mar 31, 2024 | 472,433.00 |
| Dec 31, 2023 | 57,999.00 |
| Dec 31, 2023 | 57,999.00 |
| Sep 30, 2023 | 543,863.00 |
| Sep 30, 2023 | 543,863.00 |